BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6480461)

  • 1. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
    Phuphanich S; Levin EM; Levin VA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.
    Matsutani M; Kohno T; Nagashima T; Nagayama I; Matsuda T; Hoshino T; Sano K
    Radiat Med; 1988; 6(1):33-9. PubMed ID: 3045898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
    Kinsella TJ; Russo A; Mitchell JB; Rowland J; Jenkins J; Schwade J; Myers CE; Collins JM; Speyer J; Kornblith P
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):69-76. PubMed ID: 6321412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
    Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
    Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
    Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
    Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
    J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.
    Phillips TL; Levin VA; Ahn DK; Gutin PH; Davis RL; Wilson CB; Prados MD; Wara WM; Flam MS
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):709-14. PubMed ID: 1651306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
    Mitchell JB; Kinsella TJ; Russo A; McPherson S; Rowland J; Smith BH; Kornblith PL; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):457-63. PubMed ID: 6303991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
    Eisbruch A; Robertson JM; Johnston CM; Tworek J; Reynolds KR; Roberts JA; Lawrence TS
    J Clin Oncol; 1999 Jan; 17(1):31-40. PubMed ID: 10458215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
    Kinsella TJ; Mitchell JB; Russo A; Aiken M; Morstyn G; Hsu SM; Rowland J; Glatstein E
    J Clin Oncol; 1984 Oct; 2(10):1144-50. PubMed ID: 6092551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
    Prados MD; Scott C; Sandler H; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1109-15. PubMed ID: 10613302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
    Kawano H; Hayashi M; Satoh K; Ishii H; Nakatsugawa S; Ishii Y
    No To Shinkei; 1989 Nov; 41(11):1071-5. PubMed ID: 2620008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
    Takakura K
    Gan No Rinsho; 1971 Apr; 17(4):263-8. PubMed ID: 5108090
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
    Groves MD; Maor MH; Meyers C; Kyritsis AP; Jaeckle KA; Yung WK; Sawaya RE; Hess K; Bruner JM; Peterson P; Levin VA
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):127-35. PubMed ID: 10477016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue).
    Hoshino T; Sano K
    Acta Radiol Ther Phys Biol; 1969; 8(1-2):15-26. PubMed ID: 5800876
    [No Abstract]   [Full Text] [Related]  

  • 20. BUdR radiosensitization in anaplastic astrocytoma.
    Yung WK
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1105-6. PubMed ID: 10613300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.